Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride may reduce prostate cancer risk.

Baseline PSA levels affect general health and sexual satisfaction in men with BPH treated with finasteride or placebo.

Finasteride helps increase or maintain hair in most men but can cause sexual side effects and should not be used by women, especially during pregnancy.

Chronic use of 1 mg/day finasteride for hair loss may delay prostate cancer diagnosis by lowering PSA levels.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

There is no link between hair loss and prostate enlargement.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

Large prostate patients more likely to have hair loss.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Vitamin D might help treat alopecia areata.

The man's hair turned white suddenly but returned to normal on its own in 6 months.

Canine hypothyroidism can be linked to diabetes, requiring thorough testing for proper diagnosis.

Researchers created five new human scalp cell lines that could be useful for hair growth and loss research.

Antigens from skin cells may cause hair loss in perinevoid alopecia.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Granulomatous Alopecia Areata is rare and may be caused by hair antigens or follicle destruction.

Prostate cancer screening doesn't significantly reduce death rates and has risks like overdiagnosis and side effects.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

The nail immune system is similar to hair but different from skin, with fewer immune markers.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.